Fundraising Fox

7Asqvyyszvpnum4Ftlaw4Ryxy40Krl 8Ftp8

Atlanta, US · 5 known investors

mediaspace.co ↗

Lumithera develops Valeda PBM, an FDA-authorized photobiomodulation light delivery system for treating dry age-related macular degeneration (AMD) to improve and maintain vision. The non-invasive treatment targets retinal cellular health by using specific light wavelengths to enhance mitochondrial energy production.

Advanced ManufacturingAI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHardwareHealthtechMedical DevicesSemiconductorsin /yageo@Veradigm

Founders & leadership

RP
Ronald P. ThiboutotDirector
WD
William D. McPheeDirector
JG
John G. EdwardsExecutive Officer, Director
JJ
John JacobiExecutive Officer
SP
Sri PeruvembaExecutive Officer
FJ
Francois JeanneauExecutive Officer, Director
LA
Linda AraExecutive Officer
GB
Griffith BakerDirector
MV
Michael VestelExecutive Officer
DP
Daniel PersicoDirector
GR
Gregory R. JacksonDirector

Investors · 5

3E Bioventures CapitalPalo Alto
Keiretsu ForumSan Francisco · $250K – $2M
Life Sciences Greenhouse InvestmentsHarrisburg · $250K – $500K
Toba CapitalreportedIrvine · $1M – $10M
Vivo CapitalreportedPalo Alto · $10M – $50Mvia Jack Nielsen · board

Reported raises · per SEC filings

Form D private placements
▶$22MraisedDec 2021 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jack NielsenDirector
  • William D. McPheeExecutive Officer, Director
  • Gregory R. JacksonExecutive Officer, Director
  • Ronald P. ThiboutotDirector
  • Jennifer DelPreteExecutive Officer
  • Daniel DorseyExecutive Officer
  • David MillerExecutive Officer
  • Gary VanMatreExecutive Officer
  • Nathan DauDirector
  • Carole NuechterleinDirector
  • Stephen L. RoseDirector
Offering amount
$22M
Amount sold
$22M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16MraisedNov 2020 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Carole NuechterleinDirector
  • David MillerExecutive Officer
  • Gary VanMatreExecutive Officer
  • William D. McPheeExecutive Officer, Director
  • Gregory JacksonExecutive Officer, Director
  • Dan DorseyExecutive Officer
  • Stephen L. RoseDirector
  • Ronald P. ThiboutotDirector
  • Jack NielsenDirector
  • Nathan DauDirector
Offering amount
$17M
Amount sold
$16M
Sales commissions
$170.9K
Placement agents
New Harbor Venture Partners LLC
First sale
Feb 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37.7MraisedMar 2019 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dennis J. SiegelExecutive Officer
  • David MillerExecutive Officer
  • Stephen L. RoseDirector
  • Harold MapesExecutive Officer
  • Carole NuechterleinDirector
  • Armond DantinoExecutive Officer
  • Gregory R. JacksonExecutive Officer, Director
  • Robin MattsonExecutive Officer
  • Jack NielsenDirector
  • Nathan DauDirector
  • William D. McPheeExecutive Officer, Director
  • Ronald P. ThiboutotDirector
Offering amount
$42.9M
Amount sold
$37.7M
Sales commissions
$900K
Placement agents
New Harbor Venture Partners LLC
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.5MraisedDec 2018 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William McPheeExecutive Officer, Director
  • Ronald P. ThiboutotDirector
  • Stephen R. RoseDirector
  • Gregory R. JacksonDirector
  • Dennis SiegelExecutive Officer
Offering amount
$17.5M
Amount sold
$17.5M
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9MraisedFeb 2018 · 5 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • John JacobiExecutive Officer
  • Sri PeruvembaExecutive Officer
  • Francois JeanneauExecutive Officer, Director
  • Linda AraExecutive Officer
  • Griffith BakerDirector
  • Michael VestelExecutive Officer
  • Daniel PersicoDirector
Offering amount
$14M
Amount sold
$9M
First sale
Jan 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJul 2015 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ronald P. ThiboutotDirector
  • William D. McPheeDirector
  • Gregory R. JacksonDirector
  • Stephen L. RoseDirector
  • John G. EdwardsExecutive Officer, Director
Offering amount
$5M
Amount sold
$5M
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.6MraisedJul 2015 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory R. JacksonDirector
  • Ronald P. ThiboutotDirector
  • William D. McPheeDirector
  • John G. EdwardsExecutive Officer, Director
Offering amount
$7.1M
Amount sold
$3.6M
Minimum investment
$2.4K
First sale
Jun 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.